If a protein has both an endoplasmic reticulum retention signal and a mitochondrial targeting signal sequence, where will it ultimately localize?
When a protein contains both an endoplasmic reticulum (ER) retention signal and a mitochondrial targeting signal, its final localization will depend on the relative strength of these signal sequences and the competitive mechanisms during the localization process. Generally, the following factors affect its final localization:
1. Priority Recognition Order of Signal Sequences
During protein synthesis, after translation initiation, the N-terminal signal sequence is exposed first. Therefore, if the mitochondrial targeting sequence is located at the N-terminus of the protein, it is likely to be recognized by the mitochondria and imported into the mitochondria before translation is completed. In contrast, ER retention signals (e.g., KDEL sequence) are usually located at the C-terminus or other specific sites of the protein, primarily functioning through a retrieval mechanism after entry into the ER. Thus, the priority recognition of the mitochondrial targeting signal may dominate the localization process.
2. Competitive Mechanisms of Protein Import
If a protein is recognized as mitochondrial-targeted and enters the mitochondrial matrix or inner membrane, it will bypass the ER system, and thus the ER retention signal will not function. Mitochondrial targeting signals generally have priority over ER signal sequences, especially when the mitochondrial targeting signal is at the N-terminus.
3. Influence of ER Retention Signal
In rare cases, if a protein first enters the ER, its retention signal (e.g., KDEL) will be recognized, leading to the protein being retained in the ER or retrieved back to the ER via the Golgi apparatus through KDEL receptors. However, this is uncommon as mitochondrial signals usually dominate the targeting process.
4. Conclusion
In general, proteins with N-terminal mitochondrial targeting signals are first recognized by mitochondria and imported, bypassing the ER. This priority results in the protein most likely being ultimately localized to the mitochondria. However, the specific localization outcome may vary due to differences in cell type, protein characteristics, and other regulatory mechanisms.
BiotechPack, A Biopharmaceutical Characterization and Multi-Omics Mass Spectrometry (MS) Services Provider
Related Services:
How to order?
